Drug General Information |
Drug ID |
D0R5HK
|
Former ID |
DNC001353
|
Drug Name |
Sodium valproate
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C8H15NaO2
|
Canonical SMILES |
CCCC(CCC)C(=O)[O-].[Na+]
|
InChI |
1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);/q;+1/p-1
|
InChIKey |
AEQFSUDEHCCHBT-UHFFFAOYSA-M
|
CAS Number |
CAS 1069-66-5
|
PubChem Compound ID |
|
PubChem Substance ID |
3140830, 7847775, 8149581, 11112073, 11533347, 14772519, 17405448, 24277744, 26611975, 26679345, 26747599, 26747600, 26759724, 29282141, 46580918, 50062093, 50106736, 50112990, 53777995, 56311201, 56311934, 56313007, 57260140, 57264261, 57264447, 57328420, 57381838, 76227302, 85089488, 85171019, 85231324, 91011417, 92124425, 92304110, 92307562, 99301361, 99436930, 103165510, 109613260, 117375016, 121361484, 124637890, 124757047, 124799386, 124881887, 124881888, 125163851, 125333638, 126617481, 134979762
|
ChEBI ID |
ChEBI:9925
|
SuperDrug ATC ID |
N03AG01
|
SuperDrug CAS ID |
cas=000099661
|
Target and Pathway |
Target(s) |
4-aminobutyrate aminotransferase, mitochondrial |
Target Info |
Inhibitor |
[1]
|
BioCyc Pathway
|
GABA shunt
|
Valine degradation
|
Beta-alanine degradation
|
4-aminobutyrate degradation
|
KEGG Pathway
|
Alanine, aspartate and glutamate metabolism
|
Valine, leucine and isoleucine degradation
|
beta-Alanine metabolism
|
Propanoate metabolism
|
Butanoate metabolism
|
Metabolic pathways
|
GABAergic synapse
|
PANTHER Pathway
|
Aminobutyrate degradation
|
Pyrimidine Metabolism
|
Gamma-aminobutyric acid synthesis
|
PathWhiz Pathway
|
Aspartate Metabolism
|
Glutamate Metabolism
|
Beta-Alanine Metabolism
|
Valine, Leucine and Isoleucine Degradation
|
Propanoate Metabolism
|
WikiPathways
|
GABA synthesis, release, reuptake and degradation
|
Alanine and aspartate metabolism
|
References |
REF 1 | Influence of a GABA transaminase inhibitor on central nervous system oxygen toxicity. Aviat Space Environ Med. 1978 Jul;49(7):877-9. |